Form D · Biotechnology
VeriSkin, Inc.
San Diego, CA · CIK 0001831605
Offering snapshot reported Nov 9, 2020 · SEC filing
- Reported sold
- $682K Offering amount: $1.5M
- Investors reported
- 22 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 26, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 9, 2020 | Initial | $682,336 | No comparison | 22 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-380047
$679,491.13 new money; $2,845.40 up on the exercise of warrants
Source: Form D, filed Nov 9, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mirianas Chachisvilis | Director, Executive |
| Carl Edman | Director |
| John Fitzgibbon | Director |
| Kevin Herzberg | Director |
| Eugene Tu | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
10211 Pacific Mesa Blvd Suite 404
San Diego, CA, 92121
San Diego, CA, 92121